International Patent: ANTI-NKG2D ANTIBODIES, MULTI-SPECIFIC BINDING PROTEINS, AND METHODS OF USE THEREOF

GENEVA, Oct. 9 -- DRAGONFLY THERAPEUTICS, LLC filed a patent application (US2026/021980) for “ANTI-NKG2D ANTIBODIES, MULTI-SPECIFIC BINDING PROTEINS, AND METHODS OF USE THEREOF”. With publication no. WO/2026/213346, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07K 16/28

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....